Murat Sezer, Emre Aslanger, Arif Cimen, Ebru Yormaz, Cuneyt Turkmen, Berrin Umman, Yılmaz Nisanci, Zehra Bugra and Sabahattin Umman Istanbul University,

Slides:



Advertisements
Similar presentations
Unstable Angina: Embolism Can Occur Prior to PCI Thrombus in proximal RCA Stain of muscle before injection begins: TIMI Myocardial perfusion grade 1 CM.
Advertisements

Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy.
Intracoronary Autologous Bone-Marrow Cell Transfer after Myocardial Infarction: A Double-Blind, Randomized, and Placebo-Controlled Clinical Trial Presented.
prognosis of patients with Acute Myocardial Infarction remains dismal.
Comparison of the New Mayo Clinic Risk Scores and Clinical SYNTAX Score in Predicting Adverse Cardiovascular Outcomes following Percutaneous Coronary Intervention.
Cyclosporine A reduces infarct size and has no detrimental effect of LV remodeling in STEMI patients Michel Ovize Cardiology Hospital and Inserm U886 Lyon.
Can we prevent stent restenosis after coronary stent implantation
Comparison of AngioJET Rheolytic Thrombectomy Before Direct Infarct Artery STENTing in Patients with Acute Myocardial Infarction: the JETSTENT trial David.
University Medical Center Groningen Thrombus aspiration during primary PCI FZ Thrombus Aspiration during Percutaneous coronary intervention in Acute.
BEAUTI f UL: morBidity-mortality EvAlUaTion of the I f inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction Purpose.
Francesco Liistro Cardiovascular Department, Arezzo, Italy Impact of Thrombus Aspiration on Myocardial Tissue Reperfusion and Left Ventricular Functional.
Around-the-Clock Primary Angioplasty: A Process of Care Analysis Comparing Off-Hours and Normal Hours Treatment of Acute STEMI R Leung, D Lundberg, D Galbraith,
Clinical Trial Results. org C. Michael Gibson, M.S., M.D. Director TIMI Data Coordinating Center Invasive Cardiologist Beth Israel Deaconess Medical Center.
Jay H. Traverse, MD Principal Investigator, TIME Study Minneapolis Heart Institute at Abbott Northwestern Hospital University of Minnesota Medical School.
Effects of PG , a Matrix Metalloproteinase Inhibitor to Prevent Left Ventricular Remodeling After Acute Myocardial Infarction Effects of PG ,
Department of Cardiolog Shenyang Northern Hospital
Author: Moldovan Carmen Co-authors: Opincariu Diana Balan Daniel University of Medicine and Pharmacy Tg. Mures Cardiology Clinic, Mures Emergency Clinical.
Ten-Year Follow-up Survival of the Medicine, Angioplasty, or Surgery Study (MASS-II): a Randomized Controlled Clinical Trial of Therapeutic Strategies.
Effect of Intracoronary Streptokinase Administered Immediately after Primary PCI on Left Ventricular Infarct Size, Volume and Function (J Am Coll Cardiol.
Angiographic Estimates of Myocardium at Risk During Acute Myocardial Infarction: a Validation Study Using Cardiac MRI José T. Ortiz, Sheridan N. Meyers,
Improving outcome of STEMI PCI: Preliminary Results of Crystal AMI trial Rajesh M. Dave, MD Principal investigator on behalf of Crystal AMI Investigators.
Occluded Artery Trial (OAT) Presented at The American Heart Association Scientific Session 2006 Presented by Dr. Judith S. Hochman OAT Trial.
The index of microvascular resistance measured acutely predicts infarct severity and left ventricular function at 3 months in patients with ST segment.
Beyond TIMI 3 Flow CTFC < 14 CTFC > % (n=41) (n = 18/640) (n =35/563) 2.8% p= “TIMI 4” Flow TIMI 3 Flow 14 < CTFC < % % Risk of In Hospital.
AICT 2010-Athens Interventional Cardiovascular Therapeutics XI 8-9 OCTOBER 2010 Divani Caravel Hotel, Αthens EARLY CLINICAL OUTCOMES AFTER PROMUS ELEMENT.
Maurizio Menichelli MD San Camillo Hospital, Rome ( SESAMI Trial) Maurizio Menichelli Presenter Disclosure Information Nothing to Disclose Randomized trial.
The “Code White” Team of Dr. William Ganz: 1979 Goal of IC SK Before PCI: Get the artery open.
3D ECHOCARDIOGRAPHIC ASSESSMENT OF THE CORRELATION BETWEEN REGIONAL CONTRACTILITY AND REGRESSION OF LEFT VENTRICULAR REMODELING FOLLOWING REVASCULARIZATION.
A Prospective, Randomized Evaluation of Supersaturated Oxygen Therapy After Percutaneous Coronary Intervention in Acute Anterior Myocardial Infarction.
Is the Decision-Making after Failure of CTO Angioplasty Same? Infarct Related CTO or Non- Infarct Related CTO (Continue the Procedure in Other Vessel or.
Baseline Characteristics of Patients Referred for Stress Myocardial Perfusion Testing by Erectile Function Classification James K. Min, et al, Arch Intern.
Late Open Artery Hypothesis Jason S. Finkelstein, M.D. Tulane University Medical Center 2/24/03.
BACKGROUND: COMPARATIVE ANALYSIS OF MORPHOLOGICAL EKG CHANGES AND DOOR-TO-BALLOON TIME IN STEMI Mercy P. Chandrasekaran, Jeffrey Cook, Raj Marok, Carlos.
Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki.
Clinical Trial Results. org Intracoronary Streptokinase after Primary Percutaneous Coronary Intervention Murat Sezer, Hüseyin Oflaz, Taner Gören, Irem.
Intravenous Erythropoietin in Patients with ST-Segment Elevation MI -- Study performed by: Najjar et al -- Presented by: Jay Hall PA-SII, Ali Rahimi MD.
Is there any role for intravascular ultrasound in bifurcation lesions? Giuseppe Biondi-Zoccai, MD University of Turin, Turin, Italy.
Randomized Early versus Late AbciXimab in Acute Myocardial Infarction treated with primary coronary intervention (RELAx-AMI Trial) Mauro Maioli M.D., Francesco.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Survival of patients with diabetes and multivessel.
Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.
Cardioprotective Effects of Postconditioning in Patients Treated with Primary PCI Evaluated with Magnetic Resonance Jacob T Lønborg Niels Vejlstrup, Erik.
Effect of Thrombus Aspiration in Patients With Myocardial Infarction Presenting Late After Symptom Onset Steffen Desch, MD Thomas Stiermaier, MD; Suzanne.
Date of download: 6/26/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Influence of Left Ventricular Ejection Fraction.
Date of download: 7/5/2016 Copyright © The American College of Cardiology. All rights reserved. From: Recovery of Myocardial Perfusion in Acute Myocardial.
Relationship of the TIMI Myocardial Perfusion Grades, Flow Grades, Frame Count, and Percutaneous Coronary Intervention to Long-Term Outcomes After Thrombolytic.
Impaired RV Global Longitudinal Strain Is Associated With Poor Long-Term Clinical Outcomes in Patients With Acute Inferior STEMI Journal of the American.
1 Echocardiographic Indices of Increased Left Ventricular Filling Pressure and Dilation After Acute Myocardial Infarction R2 Jungwook Kim Journal of the.
Total Occlusion Study of Canada (TOSCA-2) Trial
– р<0.05 between baseline
Use of fractional flow reserve in patients with coronary artery disease: The right choice for the right outcome  Jae Yoon Park, MD, Amir Lerman, MD, Joerg.
What about CMR in patients with acute MI?
Circ Cardiovasc Interv
Circ Cardiovasc Imaging
Catheter-Based Treatment of Coronary Artery Disease
European Heart Association Journal 2007 April
Compare-Acute Trial design: STEMI patients undergoing primary PCI were randomized to fractional flow reserve (FFR)-guided complete revascularization (n.
European Society of Cardiology 2003
Giuseppe Biondi Zoccai, MD
Figure 1 PCI strategies in patients with STEMI and multivessel disease
Nat. Rev. Cardiol. doi: /nrcardio
Intracoronary Streptokinase after Primary Percutaneous Coronary Intervention* Murat Sezer, Hüseyin Oflaz, Taner Gören, Irem Okcular, Berrin Umman, Yılmaz.
Impact of Platelet Reactivity Following Clopidogrel Administration
Significance of Periprocedural Myocardial Infarctions in Percutaneous Coronary Interventions A New Look at an Old Topic Abhiram Prasad, MD, FRCP, FESC,
Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents: 70 restenotic cases from a cohort of.
DEScover: One-Year Clinical Results
Infarct Size after Primary Angioplasty Patients With Bivalirudin
Dye strongly persistent
Evolution of Myocardial Blush after MI
A model of variation and accelerating factors in the process of acute care chain of patients with STEMI going for primary PCI. PCI, percutaneous coronary.
Figure 5. Concept of coronary flow reserve and IMR
Presentation transcript:

Murat Sezer, Emre Aslanger, Arif Cimen, Ebru Yormaz, Cuneyt Turkmen, Berrin Umman, Yılmaz Nisanci, Zehra Bugra and Sabahattin Umman Istanbul University, Istanbul Faculty of Medicine, Department of Cardiology Istanbul - Turkey Sezer, M. et al. Circ Cardiovasc Interv 2010;3:

Background: Epicardial coronary artery occlusion is accompanied by microvascular damage during the course of ST elevation acute myocardial infarction (STEMI). Degree of microvascular destruction is associated with the extent of infarction after STEMI. Over time after reperfused STEMI, microvascular function is restored in the infarcted territory and infarct size decreases. However, connection between the course of microvascular and infarct remodeling processes over time after reperfused STEMI has not been fully elucidated.

Hypothesis: We hypothesized that improvement in microvascular function over time after reperfused STEMI is related to the infarct healing process.

Aim: This study examines the association of temporal changes in hemodynamics of microcirculation in the infarcted territory and in infarct size (IS) which were assessed simultaneously in the sub- acute phase and at long-term follow-up in patients who were successfully treated with primary percutaneous coronary intervention for STEMI.

Methods: 1. Evaluation of Microvascular Perfusion  Pressure-temperature sensor-tipped guide wire (Pressure wire sensor 5, Radi Medical Systems, Uppsala, Sweden) was used.  Thermodilution-derived Coronary Flow Reserve (CFR)* = Resting mean transit time / hyperemic mean transit time *Pijls NHJ et al.. Circulation 2002;105:  Index of Microvascular Resistance (IMR)**: = Distal coronary pressure x hyperemic mean transit time **Fearon WF. et al.. Circulation. 2003;107: Evaluation of Microvascular Perfusion  Pressure-temperature sensor-tipped guide wire (Pressure wire sensor 5, Radi Medical Systems, Uppsala, Sweden) was used.  Thermodilution-derived Coronary Flow Reserve (CFR)* = Resting mean transit time / hyperemic mean transit time *Pijls NHJ et al.. Circulation 2002;105:  Index of Microvascular Resistance (IMR)**: = Distal coronary pressure x hyperemic mean transit time **Fearon WF. et al.. Circulation. 2003;107: Sezer, M. et al. Circ Cardiovasc Interv 2010;3: The patients underwent coronary angiography and microvascular function assessment at two days ( hours, n=52) and 5 - month ( weeks, n=43) after the acute event.

2. Infarct size assessment Resting technetium – 99m sestamibi SPECT studies were performed days after primary PCI (n=52) and at 5th month ( weeks) in follow-up (n=43). 3. Echocardiographic analysis Left ventricular end-systolic (LVESV) and end-diastolic volumes (LVEDV) and ejection fraction (LVEF, area-length method) were measured by echocardiography at 4 days and at 5 months.

Statistical analysis: Univariable linear regression analysis was used to evaluate the relationship between relative changes in measures of microvascular function (CFR, IMR) from baseline to long term follow-up and IS. Multivariable linear regression analysis was applied to identify the independent predictors of relative change in IS including baseline IS, pain-to balloon time, blood pressure, blood glucose level at admission and, change in measures of microvascular function into the model. Partial correlation analysis with controlling of early-phase (4 th day) IS was also performed to examine the independent relations between baseline microvascular perfusion parameters and long term IS (5 th month) and relative change in IS and relative change in microvascular perfusion parameters. The two groups were identified according to mean value of relative change in CFR and IMR: in whom percent change in improvement in CFR or IMR from baseline to 5 months follow-up were below the mean; and in whom percent change in improvement in CFR or IMR from baseline to 5 months follow-up were above the mean. Comparison of the mean value of relative changes in IS, LVEDV, LVESV, and LVEF from baseline to 5 th month follow-up between the two groups were performed by using independent t test.

52 STEMI patients Death 1 pt Refused 8 pts Two days after primary PCI (n=52) Microvasc. Evaluation Infarct size assessment Echocardiography Study patients: Restenosis in IRA 8 pts Follow-up (5- months) (n=43) Control angiography & Microvasc. Evaluation Infarct size assessment Echocardiography Final study population  35 patients who had both of the first and second SPECT imaging, measures of microvascular function and echocardiographic evaluations.

All Patients Infarct SizeCoronary Flow ReserveIndex of Microvascular Resistance Below mean (n:16) Above mean (n:19) p (BM vs AM) Below mean (n:19) Above mean (n:16) p (BM vs AM) Below mean (n:14) Above mean (n:21) p (BM vs AM) Baseline Characteristics Age, years ± ± ± ± ± ± Male, n (%) 26 (74)10 (66%)16 (84%) (68%)13 (81%)0.469 (64%)17 (80%)0.43 Smoking, n (%) 24 (68)11 (68%)13 (68%) (63%)12 (75%) (78%)13 (62%)0.46 Hypertension, n (%) 20 (57)7 (43%)13 (68%) (58%)9 (56%) (71%)10 (48%)0.29 Hyperlipidemia, n (%) 20 (57)8 (50%)12 (63%) (52%)10 (62%)0.738 (57%)12 (57%)1.00 Diabetes Mellitus, n (%) 12 (34)7 (44%)5 (26%)0.317 (36%)5 (31%)1.006 (42%)6 (29%)0.47 Infarct Characteristics Anterior MI, n (%) 20 (57)9 (56%)11 (58%) (63%)8 (50%)0.507 (50%)13 (62%)0.51 Pain-to-balloon time, min ±115197± ±119218± ±120198± MVD, n (%) 9 (25)4 (25%)5 (26%)1.006 (31%)3 (19%)0.463 (21%)6 (28%)0.48 STR, % ± ± ±1878± ±1776± Hemodynamics Heart rate, mean ± ± ± ± ± ± Blood pressure, mean ± ± ± ± ± ± Tmn Baseline, (sec.) ± ± ± ± ± ± CFR Baseline ±0.72.3± ±0.72.3± ±0.72.3± IMR Baseline, (U) ± ± ± ± ± ± IS Baseline, % ± ± ± ± ± ± Baseline Angiographic and Clinical Characteristics

Results: 1. Infarct Size: p<0.001

Results: 2. Index of microvascular resistance (IMR):

p = Results: 3. Coronary Flow Reserve (CFR):

Baseline (n =35)Follow-up (n= 35)P Infarct size, % <0.001 Index of microvascular resistance <0.001 Coronary Flow Reserve LVESV (ml) LVEDV (ml) LVEF (%) Results: Temporal changes (from baseline to 5-months follow-up) in all parameters which were used in the study [microvascular perfusion parameters, infarct size and Left ventricular volumes and function] :

CFR Group 1 (n =17)Group 2 (n=12)P Change in infarct size, % Change in LVESV, % Change in LVEDV, % Change in LVEF, % IMR Group 1 (n= 11)Group 2 (n=18)P Change in infarct size, % Change in LVESV, % Change in LVEDV, % Change in LVEF, % Comparisons of the relative changes in infarct size, left ventricular volumes and ejection fraction from baseline to long term follow-up between the two groups which were constituted according to mean values of relative changes in CFR and IMR. Group 1: In whom percent change in improvement in CFR or IMR from baseline to 5 months follow-up were below the mean value; Group 2: In whom percent change in improvement in CFR or IMR from baseline to 5 months follow-up were above the mean value. Sezer, M. et al. Circ Cardiovasc Interv 2010;3:

Comparisons of temporal changes in IS between 4 days and 5 months between the 2 groups, which were constituted according to the mean value of relative change in IMR (-33%) and CFR (41%) from baseline to 5-month follow-up Sezer, M. et al. Circ Cardiovasc Interv 2010;3:

Correlations between microvascular perfusion parameters and infarct size: The IMR, measured at two days after pPCI, correlated with 4 th day (r= 0.40, p= 0.01) and 5 th month IS (r= 0.44, p= 0.007). Relationship between early-phase IMR and 5 th month IS was still significant even after controlling for early IS (r= 0.36, p=0.03). The CFR, measured at early post-AMI phase, correlated with long term IS (r= 0.40, p= 0.009). But, there was no correlation between CFR and early infarct size. Correlation between early phase CFR and 5th month IS remained significant after controlling of early-phase IS (r= 0.35, p= 0.04).

βp Baseline infarct size 0.6<0.001 IMR CFR Predictors of 5 months infarct size

βp Change in IMR Change in CFR Predictors of the relative change in infarct size

Sezer, M. et al. Circ Cardiovasc Interv 2010;3: Correlation between relative improvements in CFR and IS from baseline to long-term follow-up

Correlation between relative improvements in IMR and IS from baseline to long-term follow-up Sezer, M. et al. Circ Cardiovasc Interv 2010;3:

Conclusions: The findings of the present study are threefold: 1. In patients with STEMI who underwent primary PCI with stenting and experienced no events during 5-month follow-up, the microvascular function in the IRA territory significantly improved. 2.This improvement of microvascular function was proportionally associated with a reduced infarct size and improved left ventricular function at follow-up. 3.The microvascular function parameters measured early after STEMI independently predicted the infarct size at follow-up.

These findings indicate that: 1. There is a strong connection between microvascular and infarct remodeling processes after reperfused STEMI. 2. Integrity and functionality of the microcirculation at the territory of the IRA is the main determinant of the evolution of infarct size. 3. Infarct size reduction is proportional to microvascular functional improvement in the long- term.

Therefore, therapeutic approaches including prevention of microvasculature during acute phase, and stimulation of reconstitution of microcirculation during follow-up may help to achieve further myocardial healing in STEMI patients.